Zeng HT, Zhang ZL, Lin XM, Peng MS, Wang LS, Xu ZL. Aluminum phosphate gel reduces early rebleeding in cirrhotic patients with gastric variceal bleeding treated with histoacryl injection therapy. World J Gastrointest Endosc 2023; 15(3): 153-162 [PMID: 37034972 DOI: 10.4253/wjge.v15.i3.153]
Corresponding Author of This Article
Zheng-Lei Xu, MD, Chief Doctor, Department of Gastroenterology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, No. 1017 Dongmen North Road, Shenzhen 518000, Guangdong Province, China. 78249073@qq.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Endosc. Mar 16, 2023; 15(3): 153-162 Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.153
Table 1 Baseline data of both groups
Characteristic
PPI group (n = 101)
PPI + APG group (n = 95)
P value
Age (yr)
51.55 ± 12.23
53.57 ± 11.90
0.245
Female/Male
26/75
31/64
0.289
MELD score
10.07 ± 3.32
9.61 ± 3.24
0.329
Prothrombin activity (%)
68.53 ± 15.48
65.63 ± 12.90
0.157
Fibrinogen (g/dL)
2.30 ± 0.76
2.09 ± 0.80
0.064
Platelet (109/L)
102.21 ± 83.68
111.16 ± 100.57
0.498
Albumin (g/dL)
3.52 ± 0.47
3.48 ± 0.58
0.622
Hemoglobin (g/dL)
9.73 ± 2.15
9.55 ± 1.88
0.524
Patients treated with beta blockers
89
86
0.586
Table 2 Comparison of varicose veins and dose of histoacryl between two groups, n (%)
Characteristic
PPI group (n = 101)
PPI + APG group (n = 95)
P value
GOV1
10 (9.90)
12 (12.63)
0.545
GOV2
50 (49.50)
41 (43.16)
0.373
GOV3
34 (33.66)
38 (40.00)
0.358
IGV1
7 (6.93)
4 (4.21)
0.408
Combine with EV need treatment
68 (67.33)
69 (72.63)
0.418
Amount of histoacryl (mL)
2.22 ± 0.80
2.21 ± 0.76
0.875
Table 3 Main outcomes of both groups, n (%)
Characteristic
PPI group (n = 101)
PPI + APG group (n = 95)
P value
Early rebleeding
13 (12.87)
3 (3.16)
0.013
Source of rebleeding
Glue extrusion ulcer
12 (11.88)
2 (2.11)
0.008
Gastric varice
1 (0.99)
1 (1.05)
> 0.999
Transfusion after rebleeding
Glue extrusion ulcer
9 (8.91)
1 (1.05)
0.030
Gastric varices
1 (0.99)
1 (1.05)
> 0.999
Re-hospitalization
10 (9.90)
2 (2.11)
0.023
6-wk mortality
0
0
> 0.999
Table 4 Other adverse events in the two groups, n (%)
Characteristic
PPI group (n = 101)
PPI + APG group (n = 95)
P value
Total complications
14 (13.86)
12 (12.63)
0.800
Abdominal pain
12 (11.88)
3 (3.16)
0.022
Constipation
2 (1.98)
9 (9.47)
0.023
Spontaneous peritonitis
0
0
> 0.999
Ectopic embolism
0
0
> 0.999
Hepatic encephalopathy
0
0
> 0.999
Citation: Zeng HT, Zhang ZL, Lin XM, Peng MS, Wang LS, Xu ZL. Aluminum phosphate gel reduces early rebleeding in cirrhotic patients with gastric variceal bleeding treated with histoacryl injection therapy. World J Gastrointest Endosc 2023; 15(3): 153-162